Goodfire AI and the Billion Dollar Bet on Neural Network Interpretability: Why Reverse Engineering Foundation Models Matters for Health Tech...
Goodfire AI, a San Francisco public‑benefit AI lab, raised a $150 million Series B in February 2026, pushing its valuation to $1.25 billion. Its Ember platform gives developers programmatic access to neural‑network internals, claiming a 58% reduction in large‑language‑model hallucinations at roughly 90 × lower cost than traditional judge‑based methods. In life‑sciences, Goodfire’s interpretability tools uncovered a novel Alzheimer’s biomarker from cfDNA fragment length and decoded the Evo 2 genomic model, leading to collaborations with Prima Mente, the Arc Institute, and Mayo Clinic. Investors such as Anthropic, B Capital, and Eric Schmidt back the company, signaling growing market confidence in mechanistic interpretability as essential infrastructure for regulated AI deployments.
Weekly Neuroscience Update
Researchers unveiled a fully implantable brain‑computer interface that lets paraplegic patients control a robotic exoskeleton with their thoughts, aiming to restore both walking and its sensation. Parallel advances include an AI pruning framework that mimics infant brain development to slash...
Resilience by Design: Building a National Network for Ambulance Services
The Ambulance Radio Programme (ARP) has built a national, dual‑data‑centre network that links 35 NHS trust sites, ensuring 24/7 availability of mission‑critical ambulance communications. Partnering with Vysiion, ARP introduced a dedicated Network Operations Centre and managed services to monitor, patch,...
Wellcome Leap Announces $2M Prize in $50M Quantum for Bio Challenge Program
Wellcome Leap announced that Algorithmiq earned the $2 million prize in its $50 million Quantum for Bio (Q4Bio) Challenge, marking the first end‑to‑end quantum‑classical workflow that simulates a photosensitizer drug for photodynamic cancer therapy. The program, launched in 2023, devoted $40 million to...
A Single Measurement Sorts Chiral Molecules by Type, Handedness, and Ratio
Researchers have unveiled a terahertz circular dichroism platform that uses an achiral gradient metasurface to identify chiral biomolecules, their handedness, and mixing ratios in a single broadband scan. The metasurface reflects terahertz light from 0.5 to 1.8 THz without adding background...
Thursday April 16, 2026 — Field Note
AI startup Luminai announced a $38 million Series B round to expand its intelligence platform across health‑system operations. The funding, led by PHTI, backs a partnership with the Cleveland Clinic, which serves roughly 15 million patients annually, focusing initially on referral‑management workflows. Luminai...
FDA Clears Endomina EZFuse System for GI Suturing
The FDA granted 510(k) clearance to Endo Tools Therapeutics’ Endomina EZFuse system, enabling U.S. commercialization of a next‑generation GI suturing platform. The device uses a single‑movement mechanism that can cut procedure time by up to 50 percent, simplifying internal stitching...
Delve Detect Enables Neurologists to Treat CNS Infections When Conventional Testing Fails
Delve Bio will showcase new data on its metagenomic sequencing service, Delve Detect, at the American Academy of Neurology 2026 meeting. A head‑to‑head study showed the test matches standard CNS panels while uncovering additional pathogens and co‑infections. Clinical cases highlighted...
Foundation Medicine to Strengthen Monitoring Portfolio with SAGA Diagnostics’ Tumor-Informed Molecular Residual Disease (MRD) Platform
Foundation Medicine announced the integration of SAGA Diagnostics' Pathlight tumor‑informed molecular residual disease (MRD) platform following Roche's definitive agreement to acquire SAGA for up to $595 million. Pathlight leverages whole genome sequencing and digital PCR to detect structural variants with ultra‑sensitive...
Promega to Showcase Oncology Research Tools and Companion Diagnostics at AACR Annual Meeting 2026
Promega will showcase a suite of oncology‑focused tools at the AACR Annual Meeting in San Diego, including its Lumit® hKi‑67 proliferation assay, the TarSeer™ BRETSA™ target‑engagement platform, and FDA‑cleared OncoMate® MSI companion diagnostic. The company also unveiled pre‑configured automated nucleic‑acid...
Government Pledges £1.5 Million for FemTech Devices
The UK government has committed roughly $1.9 million (£1.5 million) to a new FemTech healthcare challenge under its Women’s Health Strategy. The grant scheme will fund NHS trusts to partner with promising FemTech developers, especially those delivering community‑service models that address health‑inequality...
Wrightington, Wigan, and Leigh Teaching Hospitals Unveil Results of Digital Transformation
Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust partnered with Altera Digital Health to embed National Emergency Laparotomy Audit (NELA) guidance into its Sunrise electronic patient record. The digital overhaul of the Acute Abdomen Pathway drove 100% documentation compliance,...
CMS-0062-P Deep Dive: What the 2026 Interoperability and Prior Authorization for Drugs Proposed Rule Actually Means for Health Tech Investors...
CMS released the proposed rule CMS-0062-P on April 10, 2026, extending prior‑authorization interoperability to prescription drugs and mandating FHIR‑based API endpoint reporting across Medicare Advantage, Medicaid, CHIP and qualified health plans. The rule sets a comment deadline of June 15,...
38 Days Faster: How Two NHS Trusts Rewired Patient Flow Across a Region
Two NHS trusts—Kettering General Hospital and University Hospitals of Northamptonshire—implemented a Federated Data Platform that provides real‑time visibility of patient demand and capacity across organisational boundaries. The shared patient tracking lists enabled the transfer of 1,435 patients, cutting average treatment...
Avery Dennison Launches RFID Inlays Matching Major Sterilization Methods
Avery Dennison unveiled a new RFID inlay portfolio that endures the three most common medical sterilization methods, including autoclave and ethylene oxide gas. The three products—AD Minidose U9 Steri, AD Accessory U9 Steri, and AD Shelter Steri—have passed durability tests...
AscentX Medical’s Dr. Sandhu on a New Approach to Treating GERD
AscentX Medical is developing G125, a regenerative injectable biomaterial designed to reinforce the lower esophageal sphincter in patients with gastroesophageal reflux disease (GERD). The platform delivers a biocompatible scaffold via a patented needle that integrates with tissue, promoting collagen growth...
Doctor Care Anywhere Selects Tandem Health as AI Care Partner for Virtual Clinical Workflows
Doctor Care Anywhere, a leading UK digital health provider, has partnered with Tandem Health to embed its AI operating system into the virtual primary‑care platform. The integration will automatically capture consultations and generate structured medical records for the company’s 60,000...
🔬 Drowning in Medical Papers? Meet Distill Medicine
Distill Medicine launches a personalized daily feed that curates the latest medical research for clinicians and researchers. The platform aggregates papers from PubMed, medRxiv, ClinicalTrials.gov and top journals, scoring each on relevance, journal prestige, recency and citations before delivering only...
Dave Newman on Operationalizing AI in the Modern Health System — Sanford Health | VIVE 2026
Sanford Health, the nation’s largest rural health system, announced it has moved AI from isolated pilots to full‑scale operational use. Chief Medical Officer Dave Newman highlighted an agentic AI nurse that automates patient outreach and scheduling, and predictive models that...
Kevin Wang on How Ambient AI Is Solving Healthcare’s Hidden Burnout Crisis — Suki | VIVE 2026
Kevin Wang, chief medical officer of Suki, explained how the company’s ambient clinical intelligence is evolving from a simple dictation tool into a platform that embeds AI across electronic health records, telehealth and care‑management systems. By automating documentation, clinical reasoning...
Anil Jain, MD, FACP on The Prerequisite Infrastructure for Autonomous Healthcare — Innovaccer | VIVE 2026
Dr. Anil Jain, Chief Innovation Officer at Innovaccer, outlined the foundational infrastructure needed for autonomous healthcare during a VIVE 2026 interview. He highlighted the Gravity platform as an AI‑orchestration engine that links analytics to automated operational workflows, targeting high‑cost bottlenecks...
Bob Farrell on Applying E-Commerce Engagement to Healthcare — mPulse | VIVE 2026
Bob Farrell, executive at mPulse, explained how the company adapts e‑commerce engagement tactics to health‑care. By deploying conversational AI and omnichannel channels—SMS, email, rich‑media—mPulse delivers personalized outreach that nudges patients toward preventive screenings and medication adherence. Bain’s 2026 study cites...
Ania Wysocka on Democratizing Immediate Panic Attack Relief — Rootd | VIVE 2026
Rootd, a mobile app founded by Ania Wysocka, delivers instant, evidence‑based relief for panic attacks through a single‑tap CBT interface. The solution emerged as anxiety disorders surged 25% worldwide after the pandemic, overwhelming traditional therapy capacity. Rootd’s consumer‑friendly design—featuring a comforting...
Kempton Presley on Building the AI Data Foundation for Medication Adherence — AdhereHealth | VIVE 2026
Kempton Presley, CEO of AdhereHealth, emphasized that clean, unified health data is the essential foundation for any AI‑driven medication adherence solution. He warned that dirty, siloed claims and clinical feeds can cause AI hallucinations, mis‑triaging, and patient harm. AdhereHealth’s platform...
Eli Ben-Joseph on The AI Co-Pilot that Reads the Entire Medical Record — Regard | VIVE 2026
Regard’s AI co‑pilot, led by co‑founder Eli Ben‑Joseph, claims to ingest and synthesize 100% of a patient’s electronic health record in real time, addressing the industry‑wide problem that physicians only review roughly 3‑5% of available data during a typical visit....
Olivia Deitcher on Shifting From Transactional Prescriptions to Clinical Remission — Zest Health | VIVE 2026
Olivia Deitcher, founder and CEO of Zest Health, argues that specialty dermatology has become a transactional, prescription‑driven business. She highlights six‑month wait times for in‑person dermatologist appointments that leave patients with worsening chronic conditions like psoriasis. Zest Health offers a...
Maneesh Goyal on Unlocking Clinical Data for Global Discovery — Mayo Clinic Platform | VIVE 2026
Mayo Clinic Platform, led by COO Maneesh Goyal, is building a global network that pools de‑identified, longitudinal clinical data to power AI‑driven discovery. The initiative already runs more than 300 predictive algorithms that can flag disease before symptoms emerge, shifting...
Jared Goodner on Digitizing the Social Safety Net — Akido Labs | VIVE 2026
Akido Labs is building a unified data network that merges public health, emergency services, and social‑service records to capture the "dark matter" of healthcare—social determinants of health (SDOH). By overlaying SDOH data with clinical information, the platform lets care teams...
The Rise of the Generalist-Specialist
AI models are now passing specialist board exams, prompting a re‑imagining of clinical roles. Researchers propose "generalist‑specialists"—physicians who blend traditionally separate specialties such as cardiology, endocrinology and nephrology to manage disease domains holistically. This model promises fewer handoffs, faster diagnoses...
What Your Wearable Knows That Your Doctor Ignores: Weekly Livestream W/ Brooks Leitner
The Food is Health newsletter is hosting a live stream on April 17 at 2 p.m. ET with Dr. Brooks Leitner, a Yale‑trained physician‑scientist and co‑founder of VO Health. The discussion will focus on VO2 max, a fitness metric that research shows...
Elucid Announces Commercial Availability of Lesion Inspection Tool for Plaque-IQ™
Elucid announced the commercial launch of a Lesion Inspection Tool within its Plaque‑IQ software, enabling physicians to quantify plaque composition at the individual lesion level in coronary and carotid arteries. The tool provides quantitative data on high‑risk features such as...
Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries
Precision BioSciences received Clinical Trial Application approval to add sites in France and Romania to its global ELIMINATE‑B study of PBGENE‑HBV, an in‑vivo gene‑editing therapy for chronic hepatitis B. The expansion joins existing locations in the United Kingdom, Moldova, New Zealand, Hong Kong...
Briya Hits 120m Patient Journeys Milestone
Briya announced its global data network now spans over 120 million patient journeys, integrating records from the United States, European Union, Latin America, the United Kingdom, Asia and the Middle East. The expansion adds 3 million UK longitudinal records and broadens its...
Video Wednesday
Flickstop’s blog showcases two image‑only posts from 2020 and 2021 that highlight the company’s work in medical robotics—one depicting a robotic surgery and another illustrating an autonomous pandemic‑response robot. The latest entry, titled “Video Wednesday” on April 15, 2026, contains no text...
New Study on AI Clinical Decision-Making
A recent study evaluated large language model (LLM) AIs across 29 clinical vignettes, generating 16,254 responses. Scores ranged from 0.64 for Gemini 1.5 Flash to 0.78 for Grok 4, with GPT models leading overall. While final‑diagnosis accuracy was modest, failure rates for differential...
A Blunt Assessment of Every Major ACCESS Model Participant, Their Business Models, and What CMS’s New Outcome-Aligned Payment Framework Actually...
The CMS Innovation Center’s ACCESS Model launches July 5, 2026, testing an Outcome‑Aligned Payment (OAP) system for chronic‑care management across cardiometabolic, musculoskeletal and behavioral‑health tracks. Participants receive monthly fixed per‑patient payments, with half withheld until a 12‑month reconciliation that depends on meeting...
Atelerix Forms Strategic Partnership With JH Health Ltd to Expand Non-Cryogenic Cell Preservation Capabilities in the Middle East
Atelerix, a UK biotech, has signed a strategic partnership with Saudi Arabia’s JH Health Ltd, granting JH Health exclusive rights to distribute Atelerix’s non‑cryogenic hydrogel cell‑preservation solutions across the Middle East. The deal includes funding for high‑volume local manufacturing, regulatory...
StuffThatWorks Launches Research Fellows Programme
StuffThatWorks has launched a Research Fellows Program that grants ten non‑profit researchers unrestricted, free access to its massive patient‑reported real‑world dataset, which contains over 1.3 billion data points across 1,250 conditions. The program supplies SNOMED‑compatible, IRB‑approved data, built‑in analytics tools, and...
Watch: AI and Preventative Health Webinar
Health Tech World and Femtech World hosted a webinar featuring four industry leaders discussing how artificial intelligence is transforming preventative health. The panel covered AI‑driven early disease detection, personalized lifestyle recommendations, and the specific implications for women’s health innovation. Recorded...
AliveCor Launches “World First” Kardia 12L ECG in Europe
AliveCor secured CE Mark for its Kardia 12L, the world’s first AI‑powered, portable 12‑lead ECG system, and is launching it across major European markets. The device uses KAI 12L AI to detect 35 cardiac conditions, including acute myocardial infarction, from a single‑cable,...
24/7 GP Appointment Booking Is Now Live in the NHS App for More than One Million Patients
Rapid Health’s AI‑powered Smart Triage is now embedded in the NHS App, giving more than one million English patients 24‑hour, seven‑day access to GP appointments. The integration presents each user with an average of 61 available slots, with most selections...
Viewpoint: CRISPR and mRNA — Under Attack by Technology Skeptics — Poised to Save Millions of Children with Rare Diseases
Rare genetic diseases affect roughly 25 million Americans and generate about $400 billion in annual medical costs, yet fewer than five percent have FDA‑approved therapies. The scarcity of treatments stems from the economics of drug development for tiny patient pools. Recent breakthroughs...
FDA Launches READI-Home Innovation Challenge: Opportunities—And Tensions—For Home-Use Device Developers
On April 7, 2026 the FDA’s Center for Devices and Radiological Health launched the READI‑Home Innovation Challenge, a two‑phase program aimed at accelerating home‑use medical devices that can cut hospital readmissions. Developers submit a 16‑page Q‑Submission by September 30, after which up...
The ROI of Ambient AI in Health Care and Autonomous Coding
Ambient AI is moving beyond a digital scribe to reshape the entire note‑to‑bill continuum in health care. Early pilots showed 20‑40% reductions in documentation time, easing clinician burnout, but CFOs now demand measurable revenue impact. By feeding real‑time documentation into...
Apple Studio Display XDR Now Cleared for Diagnostic Radiology
Apple’s Studio Display XDR has received FDA clearance for diagnostic radiology, allowing U.S. radiologists to view medical images on the consumer‑grade monitor. The display supports DICOM presets on macOS 26.4, eliminating the need for dedicated imaging screens. Priced at $2,899,...
Big Tech’s Prescription: One Chatbot, Taken Daily
Big tech firms are launching AI chatbots that promise medical advice as U.S. healthcare costs rise and insurance coverage falls. Elon Musk’s Grok, OpenAI’s ChatGPT Health, Amazon’s Health AI agent, and Meta’s Muse Spark all market diagnostic and wellness services,...
Nanozyme Boosts Stem Cell Mitochondria to Accelerate Bone Regeneration
Researchers have engineered a single‑atom nanozyme that mimics cytochrome c oxidase, restoring mitochondrial energy production in stem cells. The nanozyme, anchored with iron and copper on a mesoporous silica scaffold and coated with triphenylphosphonium, targets mitochondria and shifts cell metabolism toward...
The Next Frontier in Precision Oncology
Precision oncology is shifting from static, single‑biopsy analyses toward dynamic, multi‑omics platforms that integrate genomics, proteomics, spatial biology and longitudinal clinical data. Over the next decade, AI will move from pattern‑recognition to causal reasoning, offering clinicians interpretable predictions that anticipate...
The Biotech Bi-Weekly: Expanding the Reach of T-Cell Engagers in Solid Tumors, a Next-Generation Chemiluminescent Immunoassay Platform and AACR Exhibitor...
The biotech bi‑weekly highlights several product launches and site expansions unveiled at the AACR Annual Meeting. Deck Bio introduced a multi‑target T‑cell engager platform aimed at overcoming heterogeneity in solid‑tumor immunotherapy. Abcam released SimpleStep Ignite™, a chemiluminescent ELISA that delivers...
NHS Investment Brings Diagnostics Closer to Home
The UK government has allocated roughly £237 million (about $301 million) to launch and expand 36 Community Diagnostic Centres (CDCs) across England. Four brand‑new CDCs will open in Gorton, Luton, Boston and Bideford during 2026/27, while 32 existing sites receive upgrades. Seventeen...